Logo image of SCR.PA

SCOR SE (SCR.PA) Stock Fundamental Analysis

Europe - EPA:SCR - FR0010411983 - Common Stock

26.4 EUR
-3.8 (-12.58%)
Last: 10/31/2025, 5:29:57 PM
Fundamental Rating

4

Taking everything into account, SCR scores 4 out of 10 in our fundamental rating. SCR was compared to 43 industry peers in the Insurance industry. SCR has a bad profitability rating. Also its financial health evaluation is rather negative. A decent growth rate in combination with a cheap valuation! Better keep an eye on SCR. SCR also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SCR had positive earnings in the past year.
Of the past 5 years SCR 4 years were profitable.
Each year in the past 5 years SCR had a positive operating cash flow.
SCR.PA Yearly Net Income VS EBIT VS OCF VS FCFSCR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

The Return On Assets of SCR (1.74%) is better than 76.74% of its industry peers.
SCR's Return On Equity of 15.11% is fine compared to the rest of the industry. SCR outperforms 60.47% of its industry peers.
SCR has a better Return On Invested Capital (2.50%) than 76.74% of its industry peers.
Industry RankSector Rank
ROA 1.74%
ROE 15.11%
ROIC 2.5%
ROA(3y)-0.63%
ROA(5y)-0.1%
ROE(3y)-4.88%
ROE(5y)-0.74%
ROIC(3y)N/A
ROIC(5y)N/A
SCR.PA Yearly ROA, ROE, ROICSCR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

SCR has a worse Profit Margin (2.70%) than 83.72% of its industry peers.
In the last couple of years the Profit Margin of SCR has declined.
SCR's Operating Margin of 5.25% is on the low side compared to the rest of the industry. SCR is outperformed by 79.07% of its industry peers.
SCR's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.25%
PM (TTM) 2.7%
GM N/A
OM growth 3Y-19.97%
OM growth 5Y-12.19%
PM growth 3Y-78.6%
PM growth 5Y-60.26%
GM growth 3YN/A
GM growth 5YN/A
SCR.PA Yearly Profit, Operating, Gross MarginsSCR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1

2. Health

2.1 Basic Checks

SCR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SCR has about the same amount of shares outstanding.
The number of shares outstanding for SCR has been reduced compared to 5 years ago.
The debt/assets ratio for SCR is higher compared to a year ago.
SCR.PA Yearly Shares OutstandingSCR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SCR.PA Yearly Total Debt VS Total AssetsSCR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

A Debt/Equity ratio of 0.81 indicates that SCR is somewhat dependend on debt financing.
The Debt to Equity ratio of SCR (0.81) is worse than 65.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.44
WACC5.68%
SCR.PA Yearly LT Debt VS Equity VS FCFSCR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SCR.PA Yearly Current Assets VS Current LiabilitesSCR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

SCR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 172.97%, which is quite impressive.
The earnings per share for SCR have been decreasing by -57.79% on average. This is quite bad
The Revenue has decreased by -6.34% in the past year.
The Revenue has been decreasing by -0.88% on average over the past years.
EPS 1Y (TTM)172.97%
EPS 3Y-76.98%
EPS 5Y-57.79%
EPS Q2Q%173.26%
Revenue 1Y (TTM)-6.34%
Revenue growth 3Y-3.61%
Revenue growth 5Y-0.88%
Sales Q2Q%-8.18%

3.2 Future

SCR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 170.20% yearly.
SCR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.33% yearly.
EPS Next Y14370.98%
EPS Next 2Y1108.45%
EPS Next 3Y437.15%
EPS Next 5Y170.2%
Revenue Next Year-5.77%
Revenue Next 2Y-1.6%
Revenue Next 3Y-0.98%
Revenue Next 5Y-0.33%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SCR.PA Yearly Revenue VS EstimatesSCR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
SCR.PA Yearly EPS VS EstimatesSCR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.71 indicates a reasonable valuation of SCR.
Compared to the rest of the industry, the Price/Earnings ratio of SCR indicates a rather cheap valuation: SCR is cheaper than 90.70% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.19. SCR is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 6.03, the valuation of SCR can be described as very cheap.
Based on the Price/Forward Earnings ratio, SCR is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SCR to the average of the S&P500 Index (22.50), we can say SCR is valued rather cheaply.
Industry RankSector Rank
PE 8.71
Fwd PE 6.03
SCR.PA Price Earnings VS Forward Price EarningsSCR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SCR is valued cheaper than 86.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.63
SCR.PA Per share dataSCR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SCR's earnings are expected to grow with 437.15% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y1108.45%
EPS Next 3Y437.15%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.99%, SCR is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.57, SCR pays a better dividend. On top of this SCR pays more dividend than 86.05% of the companies listed in the same industry.
SCR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 5.99%

5.2 History

The dividend of SCR has a limited annual growth rate of 0.57%.
Dividend Growth(5Y)0.57%
Div Incr Years1
Div Non Decr Years1
SCR.PA Yearly Dividends per shareSCR.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

SCR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP0%
EPS Next 2Y1108.45%
EPS Next 3Y437.15%
SCR.PA Yearly Income VS Free CF VS DividendSCR.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

SCOR SE

EPA:SCR (10/31/2025, 5:29:57 PM)

26.4

-3.8 (-12.58%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)07-31 2025-07-31/dmh
Earnings (Next)10-31 2025-10-31/bmo
Inst Owners49.04%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap4.74B
Revenue(TTM)23.13B
Net Income(TTM)624.00M
Analysts76.67
Price Target31.42 (19.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.99%
Yearly Dividend1.81
Dividend Growth(5Y)0.57%
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.81%
Min EPS beat(2)9.26%
Max EPS beat(2)34.36%
EPS beat(4)3
Avg EPS beat(4)-32.48%
Min EPS beat(4)-182.14%
Max EPS beat(4)34.36%
EPS beat(8)3
Avg EPS beat(8)-55.89%
EPS beat(12)6
Avg EPS beat(12)-35.39%
EPS beat(16)8
Avg EPS beat(16)-94.76%
Revenue beat(2)2
Avg Revenue beat(2)9.58%
Min Revenue beat(2)7.42%
Max Revenue beat(2)11.75%
Revenue beat(4)4
Avg Revenue beat(4)7.4%
Min Revenue beat(4)2.78%
Max Revenue beat(4)11.75%
Revenue beat(8)8
Avg Revenue beat(8)5.93%
Revenue beat(12)12
Avg Revenue beat(12)16.09%
Revenue beat(16)16
Avg Revenue beat(16)27.18%
PT rev (1m)0%
PT rev (3m)0.73%
EPS NQ rev (1m)9.46%
EPS NQ rev (3m)0.4%
EPS NY rev (1m)0%
EPS NY rev (3m)6.53%
Revenue NQ rev (1m)-0.76%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.15%
Valuation
Industry RankSector Rank
PE 8.71
Fwd PE 6.03
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB 1.46
EV/EBITDA 4.63
EPS(TTM)3.03
EY11.48%
EPS(NY)4.38
Fwd EY16.6%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS128.97
BVpS23.02
TBVpS18.09
PEG (NY)0
PEG (5Y)N/A
Graham Number39.62
Profitability
Industry RankSector Rank
ROA 1.74%
ROE 15.11%
ROCE 3.4%
ROIC 2.5%
ROICexc 2.66%
ROICexgc 3.29%
OM 5.25%
PM (TTM) 2.7%
GM N/A
FCFM N/A
ROA(3y)-0.63%
ROA(5y)-0.1%
ROE(3y)-4.88%
ROE(5y)-0.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-11.91%
ROICexgc growth 5Y-6.82%
ROICexc growth 3Y-13.22%
ROICexc growth 5Y-8.16%
OM growth 3Y-19.97%
OM growth 5Y-12.19%
PM growth 3Y-78.6%
PM growth 5Y-60.26%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA 2.32
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC5.68%
ROIC/WACC0.44
Cap/Depr(3y)19.46%
Cap/Depr(5y)36.14%
Cap/Sales(3y)0.27%
Cap/Sales(5y)0.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)172.97%
EPS 3Y-76.98%
EPS 5Y-57.79%
EPS Q2Q%173.26%
EPS Next Y14370.98%
EPS Next 2Y1108.45%
EPS Next 3Y437.15%
EPS Next 5Y170.2%
Revenue 1Y (TTM)-6.34%
Revenue growth 3Y-3.61%
Revenue growth 5Y-0.88%
Sales Q2Q%-8.18%
Revenue Next Year-5.77%
Revenue Next 2Y-1.6%
Revenue Next 3Y-0.98%
Revenue Next 5Y-0.33%
EBIT growth 1Y-13.9%
EBIT growth 3Y-22.86%
EBIT growth 5Y-12.97%
EBIT Next Year278.01%
EBIT Next 3Y62.25%
EBIT Next 5YN/A
FCF growth 1Y-39.53%
FCF growth 3Y-27.74%
FCF growth 5Y4.24%
OCF growth 1Y-38.99%
OCF growth 3Y-27.87%
OCF growth 5Y1.43%

SCOR SE / SCR.PA FAQ

What is the ChartMill fundamental rating of SCOR SE (SCR.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SCR.PA.


What is the valuation status of SCOR SE (SCR.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to SCOR SE (SCR.PA). This can be considered as Undervalued.


What is the profitability of SCR stock?

SCOR SE (SCR.PA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for SCR stock?

The Price/Earnings (PE) ratio for SCOR SE (SCR.PA) is 8.71 and the Price/Book (PB) ratio is 1.15.


How financially healthy is SCOR SE?

The financial health rating of SCOR SE (SCR.PA) is 1 / 10.